These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 12859348)

  • 1. Hippocampal dopamine D2 receptors correlate with memory functions in Alzheimer's disease.
    Kemppainen N; Laine M; Laakso MP; Kaasinen V; Någren K; Vahlberg T; Kurki T; Rinne JO
    Eur J Neurosci; 2003 Jul; 18(1):149-54. PubMed ID: 12859348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age-related dopamine D2/D3 receptor loss in extrastriatal regions of the human brain.
    Kaasinen V; Vilkman H; Hietala J; Någren K; Helenius H; Olsson H; Farde L; Rinne J
    Neurobiol Aging; 2000; 21(5):683-8. PubMed ID: 11016537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extrastriatal dopamine D2 and D3 receptors in early and advanced Parkinson's disease.
    Kaasinen V; Någren K; Hietala J; Oikonen V; Vilkman H; Farde L; Halldin C; Rinne JO
    Neurology; 2000 Apr; 54(7):1482-7. PubMed ID: 10751262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine D2 receptor bands in normal human temporal cortex are absent in Alzheimer's disease.
    Joyce JN; Myers AJ; Gurevich E
    Brain Res; 1998 Feb; 784(1-2):7-17. PubMed ID: 9518532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex differences in extrastriatal dopamine d(2)-like receptors in the human brain.
    Kaasinen V; Någren K; Hietala J; Farde L; Rinne JO
    Am J Psychiatry; 2001 Feb; 158(2):308-11. PubMed ID: 11156817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Memory and frontal lobe functions; possible relations with dopamine D2 receptors in the hippocampus.
    Takahashi H; Kato M; Hayashi M; Okubo Y; Takano A; Ito H; Suhara T
    Neuroimage; 2007 Feb; 34(4):1643-9. PubMed ID: 17174573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frontal and temporal dopamine release during working memory and attention tasks in healthy humans: a positron emission tomography study using the high-affinity dopamine D2 receptor ligand [11C]FLB 457.
    Aalto S; Brück A; Laine M; Någren K; Rinne JO
    J Neurosci; 2005 Mar; 25(10):2471-7. PubMed ID: 15758155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased dopamine D2/D3-receptor binding in temporal lobe epilepsy: an [18F]fallypride PET study.
    Werhahn KJ; Landvogt C; Klimpe S; Buchholz HG; Yakushev I; Siessmeier T; Müller-Forell W; Piel M; Rösch F; Glaser M; Schreckenberger M; Bartenstein P
    Epilepsia; 2006 Aug; 47(8):1392-6. PubMed ID: 16922886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parametric images of the extrastriatal D2 receptor density obtained using a high-affinity ligand (FLB 457) and a double-saturation method.
    Delforge J; Bottlaender M; Loc'h C; Dolle F; Syrota A
    J Cereb Blood Flow Metab; 2001 Dec; 21(12):1493-503. PubMed ID: 11740211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced D2/D3 Receptor Binding of Extrastriatal and Striatal Regions in Temporal Lobe Epilepsy.
    Bernedo Paredes VE; Buchholz HG; Gartenschläger M; Breimhorst M; Schreckenberger M; Werhahn KJ
    PLoS One; 2015; 10(11):e0141098. PubMed ID: 26544593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-related loss of extrastriatal dopamine D(2) -like receptors in women.
    Kaasinen V; Kemppainen N; Någren K; Helenius H; Kurki T; Rinne JO
    J Neurochem; 2002 Jun; 81(5):1005-10. PubMed ID: 12065612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo extrastriatal and striatal D2 dopamine receptor blockade by amisulpride in schizophrenia.
    Xiberas X; Martinot JL; Mallet L; Artiges E; Canal M; Loc'h C; Mazière B; Paillère-Martinot ML
    J Clin Psychopharmacol; 2001 Apr; 21(2):207-14. PubMed ID: 11270918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of d-amphetamine on extrastriatal dopamine D2/D3 receptors: a randomized, double-blind, placebo-controlled PET study with [11C]FLB 457 in healthy subjects.
    Aalto S; Hirvonen J; Kaasinen V; Hagelberg N; Kajander J; Någren K; Seppälä T; Rinne JO; Scheinin H; Hietala J
    Eur J Nucl Med Mol Imaging; 2009 Mar; 36(3):475-83. PubMed ID: 18985345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-related reduction of extrastriatal dopamine D2 receptor measured by PET.
    Inoue M; Suhara T; Sudo Y; Okubo Y; Yasuno F; Kishimoto T; Yoshikawa K; Tanada S
    Life Sci; 2001 Jul; 69(9):1079-84. PubMed ID: 11508650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased thalamic D2/D3 receptor binding in drug-naive patients with schizophrenia: a PET study with [11C]FLB 457.
    Talvik M; Nordström AL; Olsson H; Halldin C; Farde L
    Int J Neuropsychopharmacol; 2003 Dec; 6(4):361-70. PubMed ID: 14604451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of [11C]FLB 457 binding to extrastriatal dopamine receptors in the human brain.
    Olsson H; Halldin C; Swahn CG; Farde L
    J Cereb Blood Flow Metab; 1999 Oct; 19(10):1164-73. PubMed ID: 10532641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine D2 receptors in the hippocampus and amygdala in Alzheimer's disease.
    Joyce JN; Kaeger C; Ryoo H; Goldsmith S
    Neurosci Lett; 1993 May; 154(1-2):171-4. PubMed ID: 8361636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extrastriatal dopamine D2-receptor availability in social anxiety disorder.
    Plavén-Sigray P; Hedman E; Victorsson P; Matheson GJ; Forsberg A; Djurfeldt DR; Rück C; Halldin C; Lindefors N; Cervenka S
    Eur Neuropsychopharmacol; 2017 May; 27(5):462-469. PubMed ID: 28377075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in dopamine D2-receptor binding are associated to symptom reduction after psychotherapy in social anxiety disorder.
    Cervenka S; Hedman E; Ikoma Y; Djurfeldt DR; Rück C; Halldin C; Lindefors N
    Transl Psychiatry; 2012 May; 2(5):e120. PubMed ID: 22832965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alfentanil increases cortical dopamine D2/D3 receptor binding in healthy subjects.
    Hagelberg N; Aalto S; Kajander J; Oikonen V; Hinkka S; Någren K; Hietala J; Scheinin H
    Pain; 2004 May; 109(1-2):86-93. PubMed ID: 15082129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.